BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29210145)

  • 1. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.
    Zhou MJ; van Zante A; Lazar AA; Groppo ER; Garsa AA; Ryan WR; El-Sayed IH; Eisele DW; Yom SS
    Head Neck; 2018 May; 40(5):904-916. PubMed ID: 29210145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
    Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
    Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.
    Kim KH; Lee J; Chang JS; Lee CG; Yun M; Choi EC; Kim SH; Keum KC
    Head Neck; 2016 Oct; 38(10):1515-24. PubMed ID: 27062085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker.
    Vent J; Haidle B; Wedemeyer I; Huebbers C; Siefer O; Semrau R; Preuss SF; Klussmann J
    Head Neck; 2013 Nov; 35(11):1521-6. PubMed ID: 23345170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
    Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
    Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
    Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
    Bar-Ad V; Wang ZX; Leiby B; Tuluc M
    J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach.
    Graboyes EM; Sinha P; Thorstad WL; Rich JT; Haughey BH
    Head Neck; 2015 Nov; 37(11):1603-11. PubMed ID: 24931847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
    Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
    Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.
    Fakhrian K; Thamm R; Knapp S; Molls M; Pigorsch S; Haller B; Geinitz H
    Strahlenther Onkol; 2012 Jan; 188(1):56-61. PubMed ID: 22189437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
    Tribius S; Hoffmann AS; Bastrop S; Görögh T; Haag J; Röcken C; Clauditz T; Grob T; Wilczak W; Tennstedt P; Borcherding A; Petersen C; Hoffmann M
    Oral Oncol; 2012 Nov; 48(11):1178-84. PubMed ID: 22739067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
    Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
    Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
    Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.
    Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Saito T; Kawamori J; Tanaka Y; Hirotani Y; Homma T
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1221-1229. PubMed ID: 30756227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases.
    Mizuta M; Kitamura M; Tateya I; Tamaki H; Tanaka S; Asato R; Shinohara S; Takebayashi S; Maetani T; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Ichimaru K; Honda K; Yamada K; Omori K
    Acta Otolaryngol; 2018 Jun; 138(6):590-596. PubMed ID: 29310489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.